Literature DB >> 7876248

The effect of internal autocleavage on kinetic properties of the human cytomegalovirus protease catalytic domain.

D R O'Boyle1, K Wager-Smith, J T Stevens, S P Weinheimer.   

Abstract

The 28-kilodalton (kDa) catalytic domain of the human cytomegalovirus (HCMV) protease undergoes autoproteolytic cleavage at an internal site (I site), yielding amino-terminal 15-kDa (N15) and carboxyl-terminal 13-kDa (C13) fragments. I site autocleavage has been postulated to inactivate the protease and provide a mechanism for the negative regulation of enzyme activity during viral infection. We purified recombinant enzymes to demonstrate I site autocleavage in vitro and used site-directed mutagenesis of the I site to stabilize the protease. No difference in the kinetic properties of wild type and stabilized mutant proteases were observed in an in vitro peptide cleavage assay. The consequences of I site cleavage on enzyme activity were investigated two ways. First, autodigestion of the wild type enzyme converted the intact protease to N15 and C13 autocleavage products without a corresponding loss in enzyme activity. Second, genetic constructs encoding the N15 and C13 autocleavage products were generated and expressed separately in Escherichia coli, and each fragment was purified. An active enzyme was reconstituted by refolding a mixture of the purified fragments in vitro to form a noncovalent complex. The kinetic properties of this complex were very similar to the wild type and stabilized enzymes under optimal reaction conditions. We concluded from these studies that I site cleavage does not inactivate the HCMV protease, in the absence of other virally induced factors, and that limited potential exists for the regulation of catalytic activity by I site cleavage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876248     DOI: 10.1074/jbc.270.9.4753

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.

Authors:  Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 2.  Protease inhibitors as antiviral agents.

Authors:  A K Patick; K E Potts
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

3.  Cytomegalovirus assemblin: the amino and carboxyl domains of the proteinase form active enzyme when separately cloned and coexpressed in eukaryotic cells.

Authors:  M R Hall; W Gibson
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Independently cloned halves of cytomegalovirus assemblin, An and Ac, can restore proteolytic activity to assemblin mutants by intermolecular complementation.

Authors:  M R Hall; W Gibson
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

5.  Virus-specific interaction between the human cytomegalovirus major capsid protein and the C terminus of the assembly protein precursor.

Authors:  M Beaudet-Miller; R Zhang; J Durkin; W Gibson; A D Kwong; Z Hong
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  Characterization of a soluble stable human cytomegalovirus protease and inhibition by M-site peptide mimics.

Authors:  R L LaFemina; K Bakshi; W J Long; B Pramanik; C A Veloski; B S Wolanski; A I Marcy; D J Hazuda
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Separate functional domains of the herpes simplex virus type 1 protease: evidence for cleavage inside capsids.

Authors:  B J Robertson; P J McCann; L Matusick-Kumar; W W Newcomb; J C Brown; R J Colonno; M Gao
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Cytomegalovirus assemblin (pUL80a): cleavage at internal site not essential for virus growth; proteinase absent from virions.

Authors:  Chee-Kai Chan; Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Release of the catalytic domain N(o) from the herpes simplex virus type 1 protease is required for viral growth.

Authors:  L Matusick-Kumar; P J McCann; B J Robertson; W W Newcomb; J C Brown; M Gao
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Cloning, expression and characterization of the proteinase from human herpesvirus 6.

Authors:  N J Tigue; P J Matharu; N A Roberts; J S Mills; J Kay; R Jupp
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.